ArticleCureus2024
Early Pain Relief in Malignant Psoas Syndrome with Radiation Therapy: A Case Report.
Article in Cureus, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Pain response to palliative intent conventional radiotherapy for painful malignant iliopsoas involvement: a multicenter retrospective study.International journal of clinical oncology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Malignant psoas syndrome is caused by a malignant tumor infiltrating the psoas muscle and is characterized by severe pain. Currently, no definitive diagnostic or therapeutic approaches have been established for this condition. Although multiple medications are often used for pain relief, pain management can often be challenging, and there are various treatment options. Here, we report a case of a Japanese man in his 60s who was diagnosed with malignant psoas syndrome due to metastasis of myxoid liposarcoma. Despite undergoing several pharmacological treatments for severe pain, their effects were insufficient. Palliative radiation therapy was therefore planned and started to relieve pain. We discussed radiation therapy methods. Since there was no previous literature on treatment with single doses exceeding 3 Gy and the attending physician expected the patient to have a little longer survival time, we decided to treat 39 Gy in 13 fractions of radiation therapy. Early pain relief was achieved with 24 Gy in eight fractions. Radiation therapy was continued without change after the pain improved. The treatment was terminated at 36 Gy in 12 fractions due to the deterioration of the patient's general condition caused by the progression of metastases throughout the body. The patient died two days after the end of his treatment (18 days after the start of radiation therapy) due to exacerbation of his primary disease. No adverse events related to radiation therapy were observed. In this case, radiation therapy was found to be effective at an early stage in relieving pain from malignant psoas syndrome, which was difficult to control with multiple pharmacological treatments. Given its effectiveness in early pain relief without adverse events, radiation therapy should be actively considered as a treatment option for malignant psoas syndrome.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.